Symbicort inhaler

Symbicort is a widely recognized combination inhaler medication used globally for the long-term management of asthma and Chronic Obstructive Pulmonary Disease (COPD). It contains two active ingredients: budesonide, a corticosteroid, and formoterol, a long-acting bronchodilator. This specific medication was developed by experts in Sweden, building on the country's long history of respiratory medical innovation.

Today, Symbicort is a flagship product of AstraZeneca, a British-Swedish multinational pharmaceutical and biotechnology company. The production of the inhaler involves sophisticated manufacturing processes conducted in high-tech facilities across Europe, primarily in Södertälje, Sweden, though international demand is met through additional sites in France and the UK. As a prescription-only medication, it represents a core asset in AstraZeneca's respiratory portfolio, which continues to be a major focus of their global healthcare research and development.